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Economic aspects of dry 
cow therapy 
by Henk Hogeveen, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. 
Dry cow therapy has been part of mastitis control since the 1970s and has been one point of the 
five point scheme. In many countries 
many, if not most, dairy farmers apply 
dry cow therapy as part of their farm spe-
cific mastitis control plan. 
The general advice in the five point 
plan is that all cows, at drying off, should 
be treated with a specific long acting 
antibiotic formulation - the blanket 
method. 
The effectiveness of dry cow therapy is 
attained in two ways: 
1 By treating existing infections at the 
moment of drying off by means of long-
acting antibiotics. 
1 By treating possible infections during 
the dry period. Since not all cows have 
an intramammary infection (IMI) at the 
onset of the dry period, a certain per-
centage of IMI at the onset of the dry 
a=P(IMI, 
b=P(IMI 
P(M IMI.) 
Fig. 1. Graphical representation of the stochastic model to estimate the costs and benefits 
of dry cow therapy. 
cow period wil l cure spontaneously, and 
since not all cows wil l become infected 
during the dry cow period, many cows 
Table 1. Parameter explanation and default values of the simulation model for dry cow 
therapy. 
Parameter 
P(IMU) 
P(T*. IMI) 
PIT*, -IMI) 
P(SR) 
P(C) 
Explanation 
Probability of IMI at drying off 
Probability that a cow wil l be treated at drying 
off, given the fact that the cow has an IMI. 
When selective dry cow therapy is applied, 
this is equal to the sensitivity of the test used 
to determine cows with IMI 
Probability that a cow wil l be treated at drying 
off, given the fact that the cow has no IMI. 
When selective dry cow therapy is applied, 
this is equal to 1 -specificity of the test used to 
determine cows with IMI 
The probability that IMI at drying off wil l cure 
spontaneously 
The probability that IMI at drying off wil l cure 
as result of treatment 
Default 
0.15 
Sensitivity: 0.95' 
Specificity: 0.60' 
0.30 
0.75 
0.25 P(IMI< T*>) Probability of IMI at calving, when there was no, 
or a cured IMI at drying off, given that the cow 
was treated at drying off 
P(IMI.-Tdo) Probability of IMI at calving, when there was no 
or a cured IMI at drying off, given that the cow 
was not treated at drying off 
P(M IMIc) Probability of clinical mastitis after calving, given 
that the cow had an IMI at calving 
P(M -IMIc) Probability of clinical mastitis after calving, given 
that the cow had no IMI at calving 
' When no or blanket dry cow therapy is applied, these probabilities are respectively Oor 1. No 
literature data were available on sensitivity and specificity of selection procedures for selective 
dry cow therapy, so a rough estimation has been made, based upon experience. 
'No literature data available. 
0.10 
0.45 
0 ; 
are treated unnecessarily. This means 
that part of the dry cow treatments are 
not necessary and thus impose an eco-
nomic loss. Moreover, in certain coun-
tries (for example the Scandinavian 
countries) because of the risk of human 
resistance against antibiotics there is a 
tendency to only use dry cow therapy for 
those cows needing it. This means that 
besides no and blanket dry cow therapy, 
there is a third option: selective dry cow 
therapy. 
For the dairy farmer, economics are a 
major incentive to apply dry cow ther-
apy or not. However, there is not much 
data available about the cost effective-
ness of dry cow therapy. One study from 
the beginning of the 1990s showed that 
blanket dry cow therapy in Canadian cir-
cumstances was economically beneficial 
compared to no dry cow therapy. 
However, there was much variation in 
this study and selective dry cow therapy 
was not taken into consideration. Further 
research on the economics of dry cow 
therapy can help to clarify the discus-
sions on dry cow therapy. 
The goal of this article is to explore the 
economic aspects of dry cow therapy 
and give some insight in the mechanisms 
behind costs and benefits of dry cow 
therapy. 
To get more insight in the economic 
aspects around dry cow therapy a sto-
chastic Monte Carlo model has been 
developed. The basic unit of the model 
is a cow. At drying off a cow can have 
an IMI or not. Each cow can be treated. 
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Probabilities that an IMI wil l cure 
depend on treatment. If an IMI at drying 
off remains persistent, the cow wil l have 
IMI at calving. If the initial IMI is cured, 
or if the cow did not have an IMI at dry-
ing off, there is a probability that the cow 
wil l have an IMI at calving. 
This probability is dependent on treat-
ment. The model has been graphically 
represented in Fig. 1. 
Descriptions and default values of the 
model parameters are given in Table 1. 
The default values have been estimated 
as good as possible based on a number 
of recent publications with regard to dry 
cow therapy. Some of the parameters are 
Probabilities 
IMI at drying off (%) 
Treatment at drying off (%) 
Non cured IMI (%) 
New IMI in dry period (%) 
IMI at calving (%) 
Mastitis after calving (%) 
Costs 
Total costs ( ) 
None 
15.5 
0.0 
10.8 
24.8 
32.9 
15.1 
47 
Dry cow therapy 
Blanket 
14.6 
100.0 
3.4 
10.2 
13.3 
5.7 
25 
Selecti 
15.6 
48.9 
4.4 
17.1 
21.0 
9.4 
33 
Table 2. Simulated dynamics of infections and total costs (/cow) for default situation. 
associated with costs. When selective 
dry cow therapy is applied, there might 
be costs of selection of cows. In the 
f.i* 
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basic situation, it is assumed that this is 
done using records with regard to clini-
cal mastitis and cow somatic cell counts 
(no additional bacteriological examina-
tions). 
Therefore, the costs of selecting cows 
wil l not be high and the default value of 
this parameter wil l be 0. When applying 
bacteriological examinations for 
instance, the performance of selection 
(sensitivity and specificity) will increase, 
but also the costs of selection wil l 
increase. 
Costs for treatment have been set for 
€8.0 (at the moment of writing €1.0 = 
$US 1.0) per cow (4 injectors). These are 
approximately the costs for common dry 
cow antibiotics in the Netherlands. 
When there is an IMI during the dry 
period, either a non-cured IMI at the 
beginning of the dry period or a new IMI 
during the dry period, there wil l most 
probably be an effect on the milk pro-
duction in the following lactation. This 
effect is assumed to be a decrease of 5% 
in milk yield. 
The basic milk yield in the model is 
8.5kg per cow per lactation, which is 
approximately equal to the Dutch herd 
book average milk yield in 2001. 
Costs of a decrease in milk yield is set 
to €0.08 per kg and are based on the 
additional costs of the extra cows neces-
sary to fill the milk quotum when the 
milk yield of cows is lower. 
It is assumed that the milk quotum wil l 
be filled. 
Finally, the cost of clinical mastitis in 
the first part of lactation is assumed to be 
€277.0. The costs of clinical mastitis 
consists of treatment, lower milk produc-
tion throughout the lactation, discarding 
of milk and a higher probability of 
culling and are calculated for an average 
mastitis case, given the distribution of 
pathogens for the Dutch circumstances. 
When there is a clinical mastitis at 
calving, the milk yield decrease caused 
by IMI during the dry period wil l be set 
to zero (5%) to prevent additive effects. 
By adding random factors in the model 
(stochastic modelling), real life situations 
can be simulated. For example, random 
numbers drawn by the computer deter-
mine if a cow has IMI at drying off, 
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Study: Differences in probabilities compared to default situation 
Berry and Hillerton (2002) 0sterâs et al (1991,1994) 
New IMI dry period: 0.29 Spontaneous cure of IMI: 0.37 
New IMI dry period Cure IMI after treatment: 0.65 
with treatment: 0.06 New IMI dry period: 0.2 
New IMI dry period 
with treatment: 0.15 
Dry cow 
Blanket 
Probabilities 
IMI at drying off (%) 14.8 
Treatment at drying off (%) 100.0 
Non cured IMI (%) 3.7 
New IMI in dry period (%) 5.7 
IMI at calving (%) 9.2 
Mastitis after calving (%) 20 
Costs 
Total costs (€) 20 
therapy 
Selective 
15.5 
48.4 
4.3 
17.9 
21.8 
9.7 
34 
Dry cow 
Blanket 
14.8 
100.0 
5.3 
14.8 
19.2 
8.6 
34 
therapy 
Selective 
15.3 
48.7 
5.6 
17.0 
21.7 
10.0 
35 
Table 3. Simulated dynamics of infections and total costs (/cow) for two specific situa • 
tion as described in literature. 
whether the cow is selected to get dry 
cow therapy (in case of selective dry 
cow therapy), whether this cow is cured, 
and whether a cow gets mastitis at calv-
ing. This means that coincidence plays 
an important role, just as in real life. 
When the model is run for a large num-
ber of cows, the average of all cows wil l 
approximate the average research data. 
However, when the model is run for a 
small number of cows (for instance the 
number of cows of one farm), the aver-
age for these cows (this farm) may vary 
largely, depending on coincidence. 
Simulation results 
In this preliminary study, the basic situa-
tion, with no dry cow therapy, blanket 
dry cow therapy and selective dry cow 
therapy has been simulated for 10,000 
cows per simulation (Table 2). 
When comparing no dry cow therapy 
with blanket dry cow therapy, it can be 
noticed that treatment has an effect on 
the dynamics of IMI during the dry 
period (Table 2). 
With treatment there was a lower per-
centage of non-cured IMI, less new IMI 
in the dry period and, therefore, less IMI 
at calving, resulting in less clinical masti-
tis. When selective therapy was applied, 
under the current assumptions, the num-
ber of non-cured IMI was only slightly 
higher than under a blanket dry cow 
therapy protocol. 
However, there was more new IMI dur-
ing the dry period, resulting in more IMI 
at calving and thus more mastitis. The 
total costs (treatments, milk production 
losses and clinical mastitis) under the 
default situation were lowest for blanket 
dry cow therapy (€25) per cow per lac-
tation), while the costs for no dry cow 
therapy were highest (€47) per cow per 
lactation). 
In Fig. 2, it can be noticed that costs of 
clinical mastitis is the largest proportion 
for all situations. While with selective 
dry cow therapy, the costs of treatment 
per cow are reduced with more than 
50% compared to blanket dry cow ther-
apy €3.20 vs €7.56 per cow per lacta-
tion). 
When running the model for a number 
of cows on a farm (100 cows per farm), 
the results may differ very much per run. 
For instance, the total costs of IMI during 
the dry period (including costs of treat-
ment) varied from €10.67 to €44.88 per 
cow per year for the default situation, 
applying blanket dry cow therapy. 
The default situation is estimated based 
on a number of scientific publications 
and is some kind of average. However, 
dynamics of IMI during the dry period 
may vary to a large extent. 
The model has also been run for the sit-
uation as is specifically described by 
Berry and Hillerton (2002) and by 
0steràsetal(1991, 1994). 
Both studies differ in design and selec-
tion criteria which may have effects on 
outcome. The differences of the studies, 
compared to the default situation (as 
could be determined from the papers) 
and the results of the simulation are 
given in Table 3. 
The study of Berry and Hillerton (2002) 
showed a larger proportion of new IMI 
during the dry period and also a larger 
effect of treatment on the prevention of 
IMI during the dry period. The study of 
0steràs et al (1991, 1994), showed a 
larger spontaneous cure and a lower 
cure as result of treatment. 
Moreover, the effect of treatment on 
new IMI during the dry period was also 
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No dry cow therapy Blanket dry cow therapy Selective dry cow therapy 
Treatment Milk production loss Clinical mastitis 
Fig. 2. Losses (per cow per lactation) associated with dry cow therapy as a result of the simulation model with default values. 
Continued from page 13 
lower. The differences between both 
studies reflect in the losses associated 
with IMI in the dry period. In the study of 
Berry and Hillerton (2002), the differ-
ence between selective and blanket dry 
cow therapy increased, while in the 
study of 0sterâs et al (1991, 1994), the 
difference reduced to almost zero (see 
Table 3). 
The model presented in this article is 
only a simple model. This means that 
many effects have not been accounted 
for. For instance, the cost of clinical mas-
titis has been a fixed amount, calculated 
for Dutch circumstances. Occurrence 
and additional effects of clinical mastitis 
during the dry period have not been 
taken into account. 
There are differences in economic 
effects between high producing and low 
producing cows. Because of the type of 
breed (milk type vs dual purpose type) 
and the meat price in a country, costs for 
culling cows may differ very much 
between countries. 
The value of a lower milk yield has 
been set to €0.08 per kg. This is low, 
compared to the milk price of approxi-
mately €0.32. 
However, the value of a lower milk 
yield differs from a quota (Europe and 
Canada) to a non-quota (USA, New 
Zealand and Australia) situation. Even 
within Europe the value of a higher milk 
yield per cow differ because of regional 
price differences. 
Moreover, costs of labour have not 
been taken into account. Besides direct 
associated costs (a fixed amount per 
hour), some types of labour have a high 
emotional cost. For instance types of 
labour that are not liked and which are 
associated with problems. 
These values may differ between coun-
tries or regions. Probabilities of IMI dur-
ing, at drying off or during the dry period 
may also differ between regions and 
even between farms, since they might be 
dependent on the mastitis control man-
agement applied on the farm. 
It would be good for the discussions 
regarding dry cow therapy that the 
model would be extended and fed with 
data from various regions. 
These data should be the physiological 
data regarding probabilities of IMI at dry-
ing off and during the dry period, but 
also the costs associated with them. 
This study has only given the factors of 
importance when discussing the eco-
nomic effectiveness of dry cow therapy. 
The presented model needs to be 
extended to represent the real physiology 
of dry cow therapy in a more precise 
manner. 
Using specific input from a certain 
country or region, this extended model 
will give insight in the economic conse-
quences of a decision with regard to dry 
cow therapy. n 
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